from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1255c/-

LFCtreatmentdescriptionclass of inhibitor

0.449

Amikacinug/mL Amikacintranslation

-0.596

Cap5-10ug/mL Capreomycintranslation

-0.690

Rox10-50 ug/mL Roxithromycintranslation

-0.570

SM2-5 ug/mL Streptomycintranslation

0.228

Tet5-10 ug/mL Tetracyclinetranslation

0.535

Rif0.2-5ug/mL Rifampicintranscription

0.607

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.519

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.317

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.454

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.535

Clofazimine10-13 ug/mL Clofaziminerespiration

0.004

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.066

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.974

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.337

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.009

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.375

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.091

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.691

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.435

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.386

KCN5-20 ug/mL Potassium cyaniderespiration

0.685

NaN30.2-2 mM Sodium aziderespiration

-0.534

Nigericin50 uM Nigericinrespiration

0.515

TRC10-150 ug/mL Triclosanrespiration

0.896

TRZ10-25 ug/mL Thioridazinerespiration

-0.166

Valinomycin0.5-10 uM Valinomycinrespiration

-0.840

ZnSO42 mM ZnSO4respiration

-0.319

menadione6-10 ug/mL Menadionerespiration

0.249

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.650

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.203

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.293

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.519

NRP_1Non-replicating persistence stage 1dosRassociated

-1.153

Amp0.2mg/mL AmpicillincellWall

-0.431

Cephalexin20-100 ug/mL CephalexincellWall

-0.316

Cerulenin0.32-5 ug/mL CerulenincellWall

-2.354

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.901

EMB10-20 ug/mL EthambutolcellWall

-0.968

Eta12-40 ug/mL EthionamidecellWall

-0.841

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.165

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.035

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.523

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.851

BZA0.12 mg/mL BenzamidearomaticAmides

0.158

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.010

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.436

H2O24 mM hydrogen peroxideDNAdamaging

0.510

Levo10 ug/mL LevofloxacinDNAdamaging

0.030

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.564

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.070

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.118

UVUV-irradiationDNAdamaging

0.476

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.013

Antimycin12.5-50 ug/mL Antimycin A?

0.092

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.062

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.518

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.077

PA8240.2-2 ug/mL PA-824?

-0.719

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.514

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.129

Verapamil50 uM Verapamil?

0.568

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.156

methoxatin10-20 ug/mL Methoxatin?